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Abstract  
The primary objective of this study is to introduce a simple and flexible mathematical 
approach which models transport processes in skin using compartments. The main feature of 
the presented approach is that the rate constants for exchange between compartments are 
derived from physiologically relevant diffusional transport parameters. This allows for better 
physical interpretation of the rate constants, and limits the number of parameters for the 
compartmental model. The resulting compartmental solution is in good agreement with 
previously published solutions for the diffusion model of skin when ten or more 
compartments are used. It was found that the new compartmental model with three 
compartments provided a better fit of the previously publish water penetration data than the 
diffusion model. Two special cases for which it is difficult to implement the diffusion model 
were considered using our compartmental approach. In both cases the compartmental model 
predictions agreed well with the diffusion model.  
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Introduction 
Over the past decades, researchers have made significant efforts to better understand the skin 
and its functionalities. Morphologically, the skin is the largest organ with an area of 
approximately 2 m
2
 providing a natural barrier between the body and surrounding 
environment. Further, skin contributes to around 10% of the total body mass, and researchers 
have found that human skin is composed of 3-4 main layers [1, 2]. These layers are arranged 
from the outer to the inner layers as follows: stratum corneum (SC), viable epidermis, dermis, 
and subcutaneous tissues [1, 2]. One of the important properties of skin is its permeability 
which plays a critical role for development of new transdermal drug delivery systems 
(TDDS).  
Consequently, the understanding of drug transport from a TDDS into and through skin is 
crucial to the development of such systems, in order to achieve an optimal therapeutic effect 
[3]. Mathematical modeling of skin permeability is an important tool that can aid in the 
understanding of permeation mechanisms in dermal regions [4-6]. For example, modeling 
can help to predict the rate of penetration of drugs, as well as appropriate doses, exposure 
times, or sampling intervals. However, the validity of a mathematical model is largely 
dependent upon its capacity to predict experimental  observations well [7]. 
A considerable amount of literature has been published on mathematical models of drug 
permeability through skin. Fick’s first law deals with steady state diffusion phenomena and is 
used to predict exposure to TDDS over long time periods, when depletion in the system is not 
a significant factor [6]. In contrast, non–steady state diffusion can be analyzed by using 
Fick’s second law which is based on a time dependent approach [8]. Furthermore, 
mathematical models can be applied in transdermal drug delivery simulation to predict the 
effects of dermal exposure to external elements, as well as to analyze percutaneous 
absorption kinetics and kinematics of bio-transport phenomena [9-11]. These models can be 
developed to mathematically represent diffusional processes in the SC as either a continuum, 
or as a series of discrete compartments [12-14]. As a result, physiological complexities of the 
SC can be considerably reduced by adopting the compartmental technique [11]. In this 
approach, the skin is treated as a number of well-stirred compartments, each of which have 
uniformly distributed solute concentration. 
Compartmental or pharmacokinetic models (PK) are often used to describe the transport 
phenomena of material in biological systems, where compartments may represent different 
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sections of the body [15]. General mathematical approaches for compartmental models have 
been discussed in detail in the literature [16-18] and used for modelling drugs transport in 
skin [19, 20]. The compartmentalization of biological systems can aid in the elimination of 
space dependence in the mathematical formalism of the diffusion equation, which is 
generally a parabolic partial differential equation (PDE) [21]. As a result, a set of ordinary 
differential equations (ODEs) can be used to simulate transport processes in the transdermal 
drug delivery system instead of the PDE approach. Solving a set of ODEs is less 
computationally demanding than solving parabolic diffusion PDEs. Therefore, mathematical 
formalism of the compartmental system depends on the set of rate equations represented by 
ODEs [22]. In many instances, when rate coefficients are constant, the associated differential 
equations can be solved by Laplace transforms, but applying a numerical ODE solver is a 
more flexible and practical approach when using compartmental models.  
In this paper, we derived ODEs to simulate skin transport processes in a finite volume donor 
using a compartmental approach. We then demonstrated that the predicted flux and receptor 
concentrations using the compartmental approach were close to corresponding values for the 
previously published diffusion models [23, 24]. Although skin structural complexities and 
different types of exposure scenarios exist, they can be easily implemented in the 
compartmental approach. To illustrate the flexibility of our approach, two different cases 
were considered: i), when the diffusion coefficient is a function of concentration and ii), 
when the donor volume is reducing due to evaporation. Using the diffusion model in these 
cases necessitates a relatively complex numerical approach such as the finite difference 
method. However, the new compartmental model allows for simpler numerical solutions 
which are based on the application of standard ODE solvers and give accurate results when 
compared to the numerical solutions of the diffusion model.   
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Theory  
Anissimov and Roberts have used a diffusion model to theoretically describe two important 
cases of percutaneous absorption of a solute; firstly, when donor concentration is constant 
[23]; and secondly, when donor volume is finite [24]. In these works, models were developed 
to include such processes as donor-SC interfacial resistance, viable epidermal resistance, and 
clearance limitations in the receptor compartment. The Laplace transform technique was used 
for a wide variety of exposure scenarios of percutaneous penetration modeling [25-28]. 
However, this approach has significant limitations and cannot be applied when nonlinearities 
in the diffusion equation or time dependency in its coefficients are present [6, 29].  
Zatz has developed a five compartments model of skin in which the rate constants are 
“analogous” to the diffusion coefficient of stratum corneum [4]. Hadgraft later used a similar 
approach to check the validity of the tape stripping technique for prediction of the steady 
state flux through the skin [30]. The compartmental approach was further formalized and 
compared to the diffusion model by considering how the number of compartments influences 
the precision of the model [10]. For a constant donor concentration, ten compartments were 
found to provide sufficient accuracy [10]. In the present work, the compartmental approach is 
extended to cover situations previously addressed only within the framework of the diffusion 
model [23, 24].   
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Figure 1. (A) Schematic diagram of the diffusion model, and (B) the corresponding 
compartmental model for the constant donor concentration, and the finite vehicle volume 
systems applied on membrane (SC). 
 
Fig. 1 schematically illustrates the diffusional and the compartmental approaches. Generally, 
solute transport through the SC is assumed to be approximately described by a one 
dimensional diffusion equation [31]:  
2
2
( , ) ( , )m m
m
C x t C x t
D
t x
 

 
                                                                                                                    
(1) 
where mD  is the diffusion coefficient,  ,mC x t  is the concentration of solute in the 
membrane as a function of distance  x  and time  t . At the beginning ( 0t  ), it is assumed 
that no solute is present in the membrane and therefore the initial condition is: 
( ,0) 0mC x                                                                                                                                            
(2) 
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A second order space derivative in Equation (1) imposes two boundary conditions. The 
boundary conditions are illustrated in Fig. 1A. Firstly, at the donor surface  0x   it is given 
as [23, 24]: 
 
0
( , ) (0, )dm m
m p d
x m
C x t C t
D k C t
x K
 
   
  
                                                                                           
(3) 
Secondly, the boundary condition at the receptor surface  mx h  is: 
 ( , ) ( , ) rvem m m
m p
m rmx h
C tC x t C h t
D k
x K K
 
   
  
                                                                                     
(4) 
where  dC t and  rC t  are the concentrations in the donor and receptor phase, respectively, 
which are defined as: 
 
0
( , )d m
d m ev d
x
dC C x t
V AD Cl C t
dt x 

 

                                                                                                
(5) 
 
( , )mr
r m r r
x hm
C x tdC
V AD Cl C t
dt x 

  

                                                                                           
(6) 
where mh  is the total membrane thickness, mK , rK  are the partition coefficients between 
donor-membrane, and donor-receptor. d
pk ,
ve
pk  are the permeability coefficients of donor, and 
viable epidermis layers interface,  ,d rV V  are the volume of donor and receptor respectively, 
evCl is the clearance from the donor phase due to the evaporation of the solute, and rCl  is the 
removal rate of solution containing solute from the receptor phase. 
We aimed to introduce the compartmental model that approximates Equation (1) with the rate 
constants related to physiological parameters. The permeability coefficient pk  is often used to 
describe diffusion of a solute across biological membranes [32]. Fig. 1B shows a 
diagrammatical representation of the compartmental model, in which the SC is transformed 
into a chain of n compartments that are separated by n+1 sub-membranes with individual 
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permeability coefficients ( )i
pk . Based on this scheme and the conservation of mass principle, 
the internal compartment differential equations can be given as:  
 ( ) ( 1) ( ) ( 1)1 1      , 2 1i i i iii p i p i p i p i
dC
V A k C k C k C k C i n
dt
 
                                                               
(7) 
where A  is the area of application, iV  is the volume of the i-th compartment and 
( )i
pk  is the 
permeability coefficient of the sub-membrane between compartment i-1 and i. Generally, the 
volumes of compartments and the permeability coefficients can be non-identical   
 ( ) ( )i.e.  , for i ji j p pV V k k i j   , but here we assume that  1i mV V n  , where mV  is the 
volume of the membrane. As will be shown later, unequal permeability coefficients can 
describe a variable diffusion coefficient. Also, the number of internal compartments (n) is a 
parameter that should be selected from practical considerations, and it should not be higher 
than the number of corneocyte layers in the SC, which is about 25 [33].   
It is not practical to have more than about 4-6 unknown parameters (such as ( )i
pk ) in a model, 
as determining these parameters from experimental data is problematic. Therefore, ( )i
pk  must 
be related to physiologically based parameters, such as diffusion coefficient. One of the ways 
of achieving this is to make sure that the steady state flux  ssJ  for the compartmental model 
is equal to that of the diffusion model and all ( )i
pk  are the same. Therefore, we can impose the 
following condition on the total resistance of the membrane R: 
     
1 1
1 1
1 1 1
1
n n
m
i i i
mi ip p p
hn
R
Dk k k
 
 

      
Therefore  
( ) ( 1) , 1 1i mp
m
D
k n i n
h
                                                                                                                
(8) 
As a result, the total permeability of the SC is defined through the sum of resistances of sub-
membranes  ( )1 ipk , where the partitioning coefficient between the donor and membrane is 
taken into account by: 
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1
1
( )
1
1nsc m m
p m i
i p m
K D
k K
k h



 
  
  
                                                                                                                
(9) 
As described in Fig. 1B, the permeability between the donor and the first compartment ( (1)pk ) 
and the last compartment and the receptor ( ( 1)npk
 ) can be influenced by donor-stratum 
corneum interfacial resistance (1 dpk ) and the unstirred aqueous diffusion layer in the viable 
epidermis (1 vepk ) respectively. Therefore, these permeability coefficients are defined as:  
   
(1)
(1)
1 1
1
(1)
( 1)
1 1 1 1
1 p m
p
d d m
m
d
p p
K
k k
k Dn
k
n n h 

 
 
   

 
  
      
                                                  (10) 
   
( 1)
( 1)
1 1
1
( 1)
( 1)
1 1 1 1
1 m
n
n
pn
ve
p
m
p
ve ep v m
kK
k
Dn
k
n n hk  


 


 
  

 
   
      
                                            (11) 
where d sc
p pd k k  is the relative permeability of the donor-stratum corneum interfacial 
resistance, and ve sc
p pve k k   is the relative permeability of the unstirred aqueous diffusion 
layer in the viable epidermis in [23]. Thus, the compartmental model equations are: 
 
11
 
1 +1 1
    
     1+ 1
m
d
d ev d
dN d d
dC n
C C C
dt V t Kn

 
 
  
 
 
 
    
                                                                      
(12) 
for donor compartment,  
 
 
 1 1 2 11
 1 1
    
1+ 1
d
d d
m
n ndC
C C C C
d
K
t t n  
  
 
    
                                                                       
(13) 
for the first SC compartment,  
 
 1 1
 1
  2   , 2, , 1i i i i
d
n ndC
C C C i n
dt t
  

                                                                                
(14) 
for all SC internal compartments. The equation for the last SC compartment: 
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 
 1 1
 1 1
   
1+ 1
n
n n r
d v
m
r
n
e
n ndC
C C C C
dt n Kt
K

 
  
   
       
                                                                   
(15) 
while the equation for receptor compartment is: 
  1
1 +1
        
 1+ 1
r
n r rN r
r d
r
mN ve
KdC n
C C Cl C
dt V t n K 
 
  
       
                                                                      
(16) 
where      2 0  , , ,d m m dN dsce m m rN r mv ev p r mt h D V V V K V V KCl A k V K    and 
 rN r scr pK Al l kC C  are the characteristic time of diffusion through a membrane, 
dimensionless parameter describing ratio of the rate of solute evaporation to the rate of the 
solute absorption, donor volume number, receptor volume number, and the dimensionless 
removal rate from the receptor phase, respectively [23].  
Therefore, the flux can be given as: 
      ( 1)mn r
r
n
p
K
J t C t C t
K
k 
 
  
 
                                                                                                       
(17) 
and the total amount of solute absorbed in receptor phase is: 
   
0
t
Q t A J d                                                                                                                               
(18) 
Notably, when there is no donor-SC interfacial resistance, the unstirred aqueous diffusion 
layer in the viable epidermis i.e.  ,d ve    and the sink condition applies in the receptor 
compartment   0rC t  , the Equations (12)-(15) are identical to those previously published 
[10]. Furthermore, the compartmental model equations of the constant concentration donor 
system can be solved analytically for  Q t  with any number of compartments (n) as: 
  2
1
1 1
n i
d i ii
a r t
Q t
t e
t n r
Q
P


 
  

 
  
 


                                                                                                          
(19) 
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where 0
sc
p d dQ k A C t  , , , andi iP r a  are given as: 
 
1
 
n
i
i
j jj iP r r 

                                                                                                                              
(20)     
2 2cos , for 1 , ,
1
i
i
r i n
n
 
     
 
                                                                                                   
(21) 
( 1) / da n n t   and symbol i j  is the Kronecker delta function  1, and 0i j i j    . The 
derivation of Equation (19) is consistent with published work by Noschese et al. [34] in the 
applications of eigenvalues of special types of matrices. 
Equations (13)-(15) with dC and rC  set to zero can be used to describe the desorption of 
solute from the membrane [35, 36]. In this case the membrane is initially saturated with the 
solute, so the initial conditions are   00 for 1, ,i mC K C i n  , where 0mK C  refers to the 
initial concentration in the membrane. Also, the resultant ordinary differential equations can 
be solved analytically. 
A diagrammatic approach can be used to represent Equations (12)-(16) as a flowchart, which 
can be used in STELLA or Berkeley Madonna to perform simulations (Fig. 2).  
 
Figure 2. Diagrammatic approach for the compartmental equations, where the parameters are 
defined as:     11 11 / , , , 1/ 1 1d n dk n n t k k k k n           , 
  11/ 1 1 ven     and /i mV A h n . 
 
Diffusion coefficient as a function of concentration 
In percutaneous solute penetration scenarios, using a penetration enhancer is an example of a 
model with a diffusion coefficient as a function of concentration [29]. In this case, Equation 
(1) should be rewritten as [37-40]: 
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 m mm m
C C
D C
t x x
   
  
   
                                                                                                                 
(22) 
Finding a closed form solution of the Equation (22) [41] or even numerical solution [42, 43] 
is a challenging task. For example, solving a nonlinear partial differential equation such as 
Equation (22) can be done numerically using different sophisticated methods such as the 
finite difference method [44], or the finite element method (FEM) [45].  However, the present 
compartmental approach can be used for modeling the variable diffusion coefficient by 
modifying Equation (8) for ( )i
pk   to take  m mD C  into account. The diffusion coefficient 
 m mD C  can be represented as:  
   0m m m mD C D F C                                                                                                                        
(23) 
where 0mD  is the diffusion coefficient when the concentration of the solute in the membrane 
approaches zero, and dimensionless  mF C  (where F(0) = 1) is an explicit form of the 
diffusion coefficient as a function of the membrane concentration, which will be specified 
later. Equation (23) needs to be substituted into Equations (8), (10) and (11) with the 
concentration (Cm) replaced by the concentration in the appropriate compartment to find 
permeability coefficients between compartment, yielding: 
 
 
   
   
1
0
(1)
0
1
(1)
1
1
1
1
( 1) + 1
1 m dm m m m
d d
p p m d m p
p
m d d m
F K CK h K D
k k n F K C D k F K C h
n
k
n 



  
  
  
 
    
  
     (24) 
 ( ) 01( 1) , 2, ,
i m
p i
m
D
k n F C i n
h
                                                                                      (25) 
 
   
   
1
0
( 1)
( 1)
0
1
1
11
( 1)
1
1+ 1
nm m m m
n ve ve
p p n m p n
n
m
p
ve
F CK h K D
k k n F C D k F Cn h
n
k

 


  
  
 
 
   
  
            (26)  
In these equations 
0( )
d
p md m mk Dh K   and 0( )
v
v p m
e
mme k h D K  .  
Numerically solving differential equations with concentration dependent coefficients is a 
relatively straightforward (see Appendix A) procedure, reflecting the flexibility of the new 
approach to accommodate concentration dependent diffusion coefficient. 
  
13 
 
Various explicit forms of  mD C  have been reported [37, 44, 46-49], in this work the 
exponential form will be considered:   0
C
m mD C D e
 , where   is a constant with the unit 
of reciprocal concentration. The total flux of the solute into the receptor compartment 
becomes:  
     
 
 
 
  1
0
1
1 1
n
m m
n r
nr m
ve
C t
C t
eK D
J t C t C t
K
n
hn e


 
 
 


  
                                                                     
(27) 
where  nC t , and  rC t  can be calculated numerically (see Appendix A). The total amount 
of solute (  Q t ) can then be found using Equation (18). 
 
Reduction of donor volume due to evaporation  
Solute evaporation from the finite volume donor was previously considered [10, 50]. 
However, only the constant donor volume which is unaffected by evaporation was 
considered, so that the Laplace technique can be applied [10]. The new compartmental 
approach allows us to address the scenario where the volume of the donor reduces due to 
solvent evaporation of the donor phase. For this case, Equation (5) has to be modified to take 
the variation of donor volume into account:  
      
0
( , )m
d d m ev d
x
C x td
V t C t AD Cl C t
dt x 

 

                                                                             
(28) 
 dV t  can be expressed as:  
   0d dV t V v t                                                                                                                                   
(29) 
where 0dV  is the volume of the donor at t = 0, and  v t  determines the relative rate of solvent 
evaporation, which can be obtained from experiments. Substituting Equation (29) in (28) 
yields after some algebra: 
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   
  11  
1 1 1
     
     1+ 1
d
d ev dN d d
dN d md
C v t
v
dC n
C V t C
dt n Kt tV

 
 
 
 
 

 
    
                                  
(30) 
where  v t dv dt  . Combining Equation (30) with Equations (13)-(16) yields the 
compartmental approach for the finite donor volume with evaporation of the solvent in the 
donor phase, and this emphasizes the flexibility of the new approach to include evaporation 
scenario only by modifying equation of the donor compartment.    
As an example, an exponential reduction in the donor volume due to the solvent evaporation 
process will be considered. Such a scenario is reasonable when a volatile part of the donor 
phase evaporates. In this case  dV t  can be presented as: 
     
k tnv v se
d d dV t V V e

                                                                                                                      
(31) 
where 
 nv
dV  is the volume of the non-volatile part of the donor, 
 v
dV  is fraction of volume 
reduction due to evaporation, and parameter 
sek  is related to the rate of solvent evaporation. 
Substituting Equations (31) and (29) in (30) yields: 
      
  11
1 1
   
1+ 1     
1 vd
ev se d dN dnv v
dd dN
k t
se
dk t
se
dN m
e
K
dC n
C C k t V C
dt nt V V e



 
  
         
   
(32) 
where dimensionless donor volume number of non-volatile and volatile parts are 
     nv nvdN d m mV V K V and 
     v vdN d m mV V K V respectively.  
 
Miller and Kasting [51] modelled simultaneous absorption and evaporation from a 
multicomponent formulation applied to skin and developed a spreadsheet-based computer 
program using the diffusion model with finite difference approach. It should be possible to 
extend the compartment model to include multicomponent formulations, but is believed to be 
beyond the scope of this paper.   
 
Simulations and Data Analysis 
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The experimental SC water penetration data from previous work [36] was used. 
Compartmental model numerical simulations were performed using ode23s solver in 
MATLAB. The numerical simulations of the diffusion PDE were performed using COMSOL 
Multiphysics
®
. Talbot method [52] implemented in MATLAB was used for inverting Laplace 
transformations numerically to calculate      , and rJ t Q t C t  [23, 24].  
 
Results and Discussion  
Constant concentration donor: Experimental data for Percutaneous water penetration  
In Fig. 3 experimental data for water penetrating the SC [36] were fitted by compartmental 
and diffusion models. For the diffusion model, the cumulative amount absorbed was taken as 
   20ˆ sinhscp d d d d dQ s k A C t st s t st  [53], and the compartmental model  Q t  was 
found by numerically solving compartmental equations together with Equation (19). The 
fitted parameters using nonlinear regression in the compartmental model, which are in this 
case the characteristic diffusion time dt  and the steady state flux ssJ , have been calculated 
for a different number of compartments. Graphically, it can be seen from Fig. 3A-C that all 
models provide a good quality of fit. However, the regression quality for the compartmental 
model with 3 compartments is noticeably better for the first 30 minutes than for the diffusion 
model and compartmental models with higher number of compartments (see Fig. 3 A). Table 
1 provides the results obtained for the fitted parameters and the summary regression statistics. 
It can be seen from the table that the compartmental model with 3 compartments produces the 
highest value for MSC (model selection criterion [54], parameter similar to the Akaike 
information criterion [55, 56]). This result indicates that even for a small number of 
compartments the compartmental model has a potential to fit some data better than the simple 
diffusion model. However, applying slow binding model [36], and therefore explicitly 
accounting for a slow binding/partitioning process in the transport through SC, improves the 
fitting quality (Table 1) compared to simple diffusion model. Such direct inclusion of 
transport processes is evidently superior and we plan to explicitly include slow 
binding/partitioning to the compartmental approach in the future.    
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Figure 3. Experimental data for water penetration profiles in SC (■) and their regression 
profiles for diffusion model (▬ ▬) and compartmental model (▬) with (A) three, (B) five, and 
(C) ten compartments.  
Table 1. The results of fitting using compartmental and diffusion models 
Compartmental Model (n)  mindt  Jss (g/(cm 
2 
min)) Model Selection Criteria 
3 
5 
10 
1000 
165 ± 3.5 
170 ± 4.9 
178 ± 6.1 
192 ± 7.1 
11.6 ± 0.12
 
11.4 ± 0.16 
11.3 ± 0.18 
11.3± 0.2 
9.02 
8.26 
7.83 
7.66 
Diffusion model [53] 
Slow Binding model [36]
*
 
192± 7.1 
166.5±4.9 
11.3 ± 0.2 
11.5±0.2
 
7.66 
8.23 
* (kon = 0.019 min
-1
, koff  = 0.061 min
-1
)  
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Comparisons with the diffusion model 
Anissimov and Roberts solved Equations (3)-(6) for constant concentration donor and finite 
vehicle volume systems using Laplace domain solutions [23, 24].  In Fig. 4, fluxes for the 
compartmental model with 3, and10n   and the diffusion model for selected values of 
and , ,  ve d rN rNClV   are presented for infinite donor volume.  It can be seen from Fig. 4 that 
both models reach the same steady state flux value, as expected. Also, Fig. 4A-C shows that 
there are slight differences between models especially in the early stage with three 
compartments, whereas the impact of these differences is negligible for ten compartments, 
and this agrees with Fig. 3C. However, as shown in Fig. 4D, when the total resistance is 
mainly caused by the SC i.e. ve d   , the deviation between the models is significant.  
 
Figure 4. Comparison between normalized flux calculated by diffusion model (●) and 
compartmental model n = 3 (dashed lines), and n = 10 (solid lines) for 
 0.5, 0.5,rN rNV Cl    versus normalized time  dt t ; (A) absence of vehicle-SC 
resistance; (B) absence of epidermal resistance; (C) effect of epidermal and vehicle-SC 
resistance; (D) absence of epidermal and vehicle-SC resistance. 
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The differences between the diffusional and compartmental models (with n = 3, 5, and 10 
compartments) can be investigated by considering the maximum relative difference between 
the models for normalized flux  J  and relative difference for peak flux  peakJ  as: 
   
 
max max
max
100 %
diffusion compartment
diffusion
J t J t
J
J t


                                                                                   
(33) 
   
 
peak peak
peak
peak
100 %
diffusion compartment
diffusion
J J
J
J

                                                                               
(34) 
where maxt  is the moment when    diffusion compartmentJ t J t  reaches maximum value. 
Experimentally measuring the flux of a substance at a very early time is often not possible or 
imprecise, as the concentration in the receptor compartment is very low; therefore, the 
comparison between models for J  will only be considered for times when peak0.15t t , 
where peakt is the time to reach the maximum flux. Notably, in the constant concentration 
donor system peak ssJ J , and for peak ssJ J the relative difference for peak flux is zero. 
While varying the parameters , , , andd ve rN rNV Cl   independently over the set of values 
 0.5,1,2,4, in Equations (33) and (34), the derived median values of J for n = 3, 5, and 
10 compartments are 45%, 19%, and 7% respectively, whereas the median values of peakJ  
are 1.4%, 0.8% and 0.3% respectively. As expected, there is a clear decreasing trend in both 
J and peakJ   with the increase in the number of compartments. 
In the finite vehicle volume, varying , , , andd ve rN dN rNV V Cl   independently over the set of 
values  0.5,1,2,4, in Equations (33) and (34), the derived median values of J for n = 3, 5 
and 10 compartments are 49%, 21% and 7% respectively, whereas the median values for 
peakJ  are 1.4%, 0.7% and 0.3% respectively. Thus, the compartmental model deviation 
from the diffusion model, in both finite vehicle volume and constant concentration donor, 
reduces with the increase of the number of compartments.  
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Diffusion coefficient as a function of concentration 
Fig. 5 shows the flux for finite volume donor when the diffusion coefficient is exponentially 
dependent on concentration. Calculations were performed for 1dNV   and 0 0,1, 5dC   for 
compartmental and diffusion models. 
 
 
Figure 5. Normalized flux calculated by diffusion (solid lines) and compartmental models 
with n 3 (dotted lines), 5 (dash dotted lines) and 10 (dashed lines) versus the normalized 
time profiles  dt t  for   0 ;
C
m mD C D e
 (A) 0 0 ;dC  (B) 0 1dC  ; (C) 0 5.dC   
 
Fig. 5 shows that the flux for compartmental model approaches that of the diffusion model as 
the number of compartments increases. It can be seen that a difference between models in 
terms of peak flux  maxJ  and peak time  max  reduces with the number of compartments.  
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Figure 6. Cumulative amount absorbed calculated by the compartmental model with ( 25n 
▬) and diffusion model (▲▲▲ 0 0dC  ; ●●● 0 1dC  ; ■■■ 0 5dC  ) versus 
normalized time profile  dt t  for 1dNV  .  
 
Fig. 6 shows a cumulative amount absorbed for the diffusion model and compartmental 
model with 25 compartments. It can be seen that the difference between the models is 
negligible when large number of compartments are considered. Notably, increasing the 
parameter   reduces the time when 90% of the dose is absorbed through the SC. This is 
expected, as  describes the rate of increase of the diffusion coefficient, and thus the rate of 
permiation, with the icrease in concentration.   
 
Reduction of vehicle volume due to solvent evaporation 
In Fig. 7, the normalized flux  J t  is plotted versus normalized time ( dt t ) for the following 
parameters: , , , , 0d ve rN rN evV Cl    , and two different values of 1, and 5dk t  , which 
describe different rates of solvent evaporation. Fig. 7 illustrates that for the higher value of 
solvent evaporation ( 5dk t  ) the higher values of flux are achieved. This is expected, as the 
concentration in the donor phase would be higher when the donor volume reduces faster due 
to the faster solvent evaporation. In addition, as in previous cases, the compartmental model 
predictions approach rapidly to that of the diffusion model with the increase in the number of 
compartments.  
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Figure 7. Normalized flux calculated by diffusion model using FEM approach (solid lines) 
and compartmental model with n  (3 dotted lines, 5 dash dotted lines, 10 dashed lines) 
versus normalized time profile  dt t  for the case where solvent evaporates exponentially 
with 
   
0 ; 0 51; .5 .
nv
Nd dNN
v
dV V V  . 
 
Conclusion 
In this work, a new compartmental model describing solute transport in the SC has been 
developed. The present model offers a simplified approach for modeling a wide variety of 
exposure scenarios in percutaneous drug delivery systems, including the simulation of skin 
transport processes in transdermal drug delivery systems with a finite volume donor. The 
results were in good agreement with the diffusion model. The mathematical flexibility of the 
new approach should be easily expandable to include modelling transport in different skin 
layers. In addition, our study provides a flexible framework for assessing performance 
characteristics of various TDDS. In summary, the present compartmental approach is a 
relatively simple technique with wide ranging applicability to solving problems related to 
transport phenomena in skin and other membranes. 
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Appendix A 
The compartmental model equations with a diffusion coefficient as a function of 
concentration can be given, after substituting  ( ) 0 1( 1)
i
p m i mk n D F C h   in Equations (12)-
(16), as: 
Donor compartment: 
   
   
 1
1
11
  
     1+ 1
m dd
d ev d
dN d d
d
mm d
m
F K
F K
KF K
n CdC C
C C C
dt V t n C

 
   
   
    
                               
(A.1)                          
 First SC compartment:                                                                    
   
   
     1 1 2 1 11
 1
    
1+ 1
d
d
d d
m
m d
m
Cn n F K
K F
F K
dC
C C C C C
dt t n C  
 
      
                                 
(A.2)                                                  
All SC internal compartments:                                                                                           
 
        11 1
 1
       , 2, , 1i i ii i i i
d
n ndC
C C C C C C i n
dt t
F F 

                                         
(A.3)                                              
Last SC compartment:                                                                                                   
 
   
 
   
11 1
 1
   
1+ 1
nn
nn n r n
d n ve
m
r
F K
F
F
Cn ndC
C C C C C
dt t n C K
 
   
         
                            
(A.4)                                           
Receptor compartment:                                                                                       
   
    1
11
        
 1+ 1
nr
n r rN r
rN d n ve
r
m
n CdC
C C Cl C
dt V t n
F K
KCF  
   
        
                                                 
(A.5)                                                                                                                                                                                                          
Solving the new equations can be done numerically with initial conditions such as  
   00 , 0 0, 1, ,d d iC C C i n    after the function  mF C  is specified. 
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